uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted December 02, 2020

FDA Warns Sellers of Unapproved COVID-19 Tests, CBD Products

On November 23 and November 30, 2020, the FDA issued warning letters to Industry Lab Diagnostic Partners and Avazo-Healthcare, LLC, respectively, for selling unapproved, adulterated, and misbranded tests for coronavirus (COVID-19).

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at